Revumenib Physiologically Based Pharmacokinetic (PBPK) Model for Evaluation of Age Effect and CYP3A4-mediated Drug-Drug Interaction (DDI) in Relapsed /Refractory Acute Leukemias

Abstract | Oct 10, 2024

Author

Chapron A, et al.

Congress

American Conference on Pharmacometrics 2024

Phoenix, Arizona | Oct 10 – 13, 2024